Abstract
SUMMARY.— After a brief review of the anti-allergic and anti-inflammatory properties of E-ACA, the therapeutic results of E-ACA in atopic dermatitis, anetoderma of Jadassohn and cold urticaria are reported. Among 21 patients with atopic dermatitis, 2 failed to return, 2 discontinued treatment on account of nausea, 9 responded favourably, and 5 showed only a fair response. Two patients showed no improvement. Eleven patients, with chronic atopic dermatitis, under corticosteroid therapy, were weaned off corticosteroids and treated with E-ACA and gave a favourable response. A patient with anetoderma showed complete remission of the disease 4 years after discontinuing therapy. The patient with cold urticaria was relieved to such a degree during therapy that, during freezing temperature, outdoor life was tolerable.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
